Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Senna + docusate is an oral combination medication used to treat occasional constipation. It contains two active ingredients with complementary mechanisms of action: - **Senna** (sennosides) is a stimulant laxative that increases intestinal motility by stimulating the smooth muscle of the colon. This promotes bowel movements by increasing peristalsis. - **Docusate** is a stool softener (emollient laxative) that works by increasing the amount of water in the stool. This makes stools softer and easier to pass. The combination provides both stimulation for bowel movement and softening of stool for more effective relief from constipation. It is typically used short-term and should not be taken for more than 7 days without medical supervision[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on senna + docusate.